Skip to main content
. Author manuscript; available in PMC: 2008 May 14.
Published in final edited form as: Biol Psychiatry. 2007 Oct 29;63(9):891–898. doi: 10.1016/j.biopsych.2007.09.012

Figure 3.

Figure 3

Hippocampal N-acetylaspartate of healthy volunteers (untreated) and generalized anxiety disorder patients at Baseline MRSI scan and Week 8 MRSI scan (8 weeks of riluzole, 50 mg b.i.d.).